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Abstract 
The histochemical and ultrastructural analy-
sis of the nuclear components involved in RNA
transcription and splicing can reveal the occur-
rence of cellular dysfunctions eventually relat-
ed to the onset of a pathological phenotype. In
recent years, nuclear histochemistry at light
and electron microscopy has increasingly been
used to investigate the basic mechanisms of
skeletal muscle diseases; the in situ study of
nuclei of myofibres and satellite cells proved to
be crucial for understanding the pathogenesis
of  skeletal  muscle  wasting  in  sarcopenia,
myotonic dystrophy and laminopathies.
In recent years, histochemistry has become
a popular approach to investigate the structur-
al organization and function of skeletal muscle
cells,
1-8 being widely used as a diagnostic tool
in  neuromuscular  disorders.
9,10 In  particular,
the cytochemical analysis of the cell nucleus
has been applied more and more frequently for
investigating the basic mechanisms of skeletal
muscle diseases.
In the cell nucleus, genes are transcribed
and the primary transcripts undergo molecular
processing which generates mature RNAs to
be  exported  into  the  cytoplasm.  The  events
leading to the formation of mature RNAs are
chronologically and spatially ordered, and they
mostly  occur  on  distinct  ribonucleoprotein
(RNP)-containing structures.
11,12These nuclear
components have specific locations, and this is
a necessary prerequisite for the correct pro-
cessing  of  nuclear  RNAs  to  occur,  so  that
whenever  transcription  and/or  splicing  are
altered,  the  organization,  composition,  and
intranuclear location of RNP-containing struc-
tures are also affected.
13-16 As a consequence,
the in situ analysis of the nuclear organization
and molecular composition in muscle cells not
only provides information about the DNA/RNA
pathways which govern myofibre metabolism,
but also may reveal the occurrence of dysfunc-
tions related to the pathological phenotype of
diseased skeletal muscle.
Recently, ultrastructural immunocytochemi-
cal  investigation  of  cell  nuclear  components
has been applied to study sarcopenia,
17,18 i.e.
the age-related condition characterized by the
decline of muscle mass, strength and quality,
which is responsible for frailty, disability and
premature  death  in  elderly.
19 The  cellular
mechanisms involved in the onset of sarcope-
nia  are  probably  manifold,  and  they  still
remain to be completely elucidated.
20,21 One of
the possible causes is the remarkable decline
in  the  efficiency  of  muscle  regeneration,
which has been associated with a decrease in
the number of satellite cells and/or with the
alteration of their proliferation and differenti-
ation potential.
22,23 Consistent with this hypoth-
esis, through the in situanalysis of the nuclear
RNP-containing structures involved in the dif-
ferent steps of mRNA formation, it has recent-
ly been demonstrated that satellite cells of old
muscles exhibit a significantly reduced activi-
ty of pre-mRNA splicing and cleavage, which
hampers their responsiveness to muscle dam-
age.
18 In addition, the cytochemical approach
allowed to demonstrate that the entire produc-
tion chain of mRNA, from its synthesis to the
export into the cytoplasm, is impaired in the
myonuclei of old muscles:
17 this would likely
contribute  to  the  reduced  responsiveness  of
muscle fibres to anabolic stimuli, as it typical-
ly  occurs  in  elderly.  It  may  be  inferred  that
many  of  the  structural  and  functional  alter-
ations occurring in old muscles could be the
phenotypic expression of a failure in nuclear
functions.  Accordingly,  when  the  sarcopenic
process is prevented by physical activity,
24,25 the
cell nuclei of senescent skeletal muscles show
the RNP pattern typical of the adult age (per-
sonal unpublished results). It is worth noting
that in hibernating mammals the muscle mass
is maintained even after long periods of inac-
tivity  (which  may  last  for  months,  in  some
species): in the skeletal muscles of hibernat-
ing  mammals  the  nucleus  displays  “active”
characteristics,
26 thus suggesting that preser-
vation  of  the  myofibre/muscle  structure
implies the maintenance of a correct nuclear
functionality.
Defects  in  the  RNA  maturation  pathways
have also been related to diseases leading to
muscle dystrophy: in both the myotonic dystro-
phy type 1 (DM1) and type 2 (DM2) the expan-
sion  of  two  distinct  nucleotidic  sequences
((CTG)n in the 3’ untranslated region of the
DMPK gene on chromosome 19q13 in DM1
27-29
and (CCTG)n in the first intron of the ZNF9
gene on chromosome 3q21 in DM2
30,31) causes
pathologies characterized by a variety of multi-
systemic features including myotonia (muscle
hyperexcitability), muscular dystrophy, dilated
cardiomyopathy,  cardiac  conduction  defects,
cataracts, insulin-resistance, and disease-spe-
cific serological abnormalities such as hyper-
glycemia and gamma-glutamyltransferase ele-
vations,  hypotestosteronism,  and  decreased
levels  of  IgG  and  IgM  immunoglobulins.
Combining  biomolecular  and  cytochemical
techniques, it has been demonstrated that the
basic mechanisms of both DMs reside in the
nuclear sequestration of the expanded RNAs:
CUG- and CCUG-containing transcripts accu-
mulate in intranuclear foci in DM1 and DM2
cells respectively, and alter the regulation and
intranuclear  localization  of  the  RNA-binding
proteins CUGBP1 and MBLN, which are neces-
sary  for  the  physiological  processing  of  pre-
mRNA.
31-37 A recent study based on immunocy-
tochemical  analyses  at  light  and  electron
microscopy
38 has  demonstrated  that  MBNL1-
containing  foci  in  DM2  cells  also  sequester
snRNPs and hnRNPs, splicing factors involved
in the early phases of transcript processing;
11
this strengthens the hypothesis that the multi-
factorial  phenotype  of  dystrophic  patients
could be due to a general alteration of the pre-
mRNA post-transcriptional pathway.
Laminopathies represent a family of multi-
systemic disorders resulting from mutations in
the LMNA gene on chromosome 1q21, encod-
ing nuclear lamins A and C. They include sev-
eral  distinct  disease  phenotypes,  many  of
which characterised by skeletal muscle dystro-
phy.
39 Also in this case, the combination of bio-
molecular and cytochemical studies revealed
that the basic mechanisms of the pathological
features  reside  in  the  nucleus,  where  pre-
lamin  A  is  accumulated,  heterochromatin
undergoes a severe disorganisation and many
heterochromatin-associated  proteins  show
altered  properties.
39-42 This  defective  hete-
rochromatin remodelling affects gene expres-
sion  thus  causing  a  cascade  of  epigenetic
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events altering several systems.
The analysis in situ of the cell nucleus may
therefore  represent  a  decisive  approach  for
understanding the basic mechanisms leading
to fibre muscle loss/disorganization, which is
crucial for the development of effective inter-
ventions to fight physical disability. This type
of  investigation  requires  that  sufficient
amounts  of  bioptic  material  are  adequately
removed and processed in order to obtain reli-
able results; however, this is scarcely compati-
ble  with  the  surgical  needs  and,  for  a  long
time, this restriction has limited the applica-
tion of in situ techniques to investigate muscle
physiopathology.  The  recent  demonstration
that routinely frozen biopsies of human skele-
tal muscle can be successfully processed for
morphological and immunocytochemical stud-
ies  at  transmission  electron  microscopy
43
opens  promising  perspectives  for  multiple
exploitation  of  the  bioptic  muscle  samples
stored in tissue banks, especially for the study
of rare muscle diseases.
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